{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:22:22Z","timestamp":1792318942582,"version":"4.4.0"},"reference-count":32,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Preclinical studies of chemoprevention drugs given in combination at low doses show remarkable efficacy in preventing adenomas with little additional toxicities, suggesting a strategy to improve risk to benefit ratios for preventing recurrent adenomas. Three hundred seventy-five patients with history of resected (\u22653 mm) adenomas were randomly assigned to receive oral difluoromethylornithine (DFMO) 500 mg and sulindac 150 mg once daily or matched placebos for 36 months, stratified by use of low-dose aspirin (81 mg) at baseline and clinical site. Follow-up colonoscopy was done 3 years after randomization or off-study. Colorectal adenoma recurrence was compared among the groups with log-binomial regression. Comparing the outcome in patients receiving placebos to those receiving active intervention, (a) the recurrence of one or more adenomas was 41.1% and 12.3% (risk ratio, 0.30; 95% confidence interval, 0.18-0.49; P &amp;lt; 0.001); (b) 8.5% had one or more advanced adenomas, compared with 0.7% of patients (risk ratio, 0.085; 95% confidence interval, 0.011-0.65; P &amp;lt; 0.001); and (c) 17 (13.2%) patients had multiple adenomas (&amp;gt;1) at the final colonoscopy, compared with 1 (0.7%; risk ratio, 0.055; 0.0074-0.41; P &amp;lt; 0.001). Serious adverse events (grade \u22653) occurred in 8.2% of patients in the placebo group, compared with 11% in the active intervention group (P = 0.35). There was no significant difference in the proportion of patients reporting hearing changes from baseline. Recurrent adenomatous polyps can be markedly reduced by a combination of low oral doses of DFMO and sulindac and with few side effects.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-08-0042","type":"journal-article","created":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T20:36:28Z","timestamp":1208205388000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":438,"title":["Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial"],"prefix":"10.1158","volume":"1","author":[{"suffix":"Jr.","given":"Frank L.","family":"Meyskens","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"McLaren","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pelot","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Fujikawa-Brooks","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Hawk","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Kelloff","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lawson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashri","family":"Kidao","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCracken","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Gregory","family":"Albers","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Ahnen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Kim","family":"Turgeon","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Goldschmid","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lance","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt H.","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Gillen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene W.","family":"Gerner","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; 2Arizona Cancer Center, University of Arizona, Tucson, Arizona; 3Department of Veterans Affairs Long Beach Healthcare System, Long Beach, California; 4Loma Linda University, Loma Linda, California; 5University of Michigan, Ann Arbor, Michigan; 6Denver Department of Veteran Affairs Medical Center and University of Colorado, Denver, Colorado; 7Kaiser Permanente, Sacramento, California; 8University of Kansas, Kansas City, Kansas; and 9National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,6,9]]},"reference":[{"key":"2022060815280835000_ bib1","first-page":"1","article-title":"Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics S. Deaths: final data for 2004","volume":"55","author":"Minino","year":"2007","journal-title":"Natl Vital Stat Rep"},{"key":"2022060815280835000_ bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2022060815280835000_ bib3","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy","volume":"329","author":"Winawer","year":"1993","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2004.09.052","article-title":"Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?","volume":"127","author":"Seeff","year":"2004","journal-title":"Gastroenterology"},{"key":"2022060815280835000_ bib5","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.296.23.2815","article-title":"Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer","volume":"296","author":"Gross","year":"2006","journal-title":"JAMA"},{"key":"2022060815280835000_ bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26980-0_1","article-title":"Lifestyle and medical approaches to cancer prevention","volume":"166","author":"Greenwald","year":"2005","journal-title":"Recent Results Cancer Res"},{"key":"2022060815280835000_ bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200004203421602","article-title":"Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas","volume":"342","author":"Alberts","year":"2000","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199901143400204","article-title":"Calcium supplements for the prevention of colorectal adenomas","volume":"340","author":"Baron","year":"1999","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","article-title":"A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas","volume":"131","author":"Baron","year":"2006","journal-title":"Gastroenterology"},{"key":"2022060815280835000_ bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ncponc0609","article-title":"The dilemma and promise of cancer chemoprevention","volume":"3","author":"Lippman","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"2022060815280835000_ bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/287107a0","article-title":"Combination chemoprevention of cancer","volume":"287","author":"Sporn","year":"1980","journal-title":"Nature"},{"key":"2022060815280835000_ bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/79534","article-title":"Combinatorial chemoprevention of intestinal neoplasia","volume":"6","author":"Torrance","year":"2000","journal-title":"Nat Med"},{"key":"2022060815280835000_ bib18","first-page":"1309","article-title":"Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil","volume":"77","author":"Nigro","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"2022060815280835000_ bib19","first-page":"945","article-title":"Development of difluoromethylornithine (DFMO) as a chemoprevention agent","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2022060815280835000_ bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00726-007-0515-2","article-title":"Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention","volume":"33","author":"Gerner","year":"2007","journal-title":"Amino Acids"},{"key":"2022060815280835000_ bib21","first-page":"1155","article-title":"Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine","volume":"9","author":"Lawson","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815280835000_ bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"2022060815280835000_ bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.0006-341X.1999.00874.x","article-title":"A unifying family of group sequential test designs","volume":"55","author":"Kittelson","year":"1999","journal-title":"Biometrics"},{"key":"2022060815280835000_ bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.0006-341X.2003.00090.x","article-title":"Flexible implementations of group sequential stopping rules using constrained boundaries","volume":"59","author":"Burington","year":"2003","journal-title":"Biometrics"},{"key":"2022060815280835000_ bib25","doi-asserted-by":"crossref","DOI":"10.1201\/9780367805326","volume-title":"Group sequential methods with applications to clinical trials","author":"Jennison","year":"1999"},{"key":"2022060815280835000_ bib26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/jnci\/86.15.1122","article-title":"Dose de-escalation chemoprevention trial of \u03b1-difluoromethylornithine in patients with colon polyps","volume":"86","author":"Meyskens","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"2022060815280835000_ bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/90.16.1212","article-title":"Effect of \u03b1-difluoromethylornithine on rectal mucosal levels for polyamines in a randomized, double-blinded trial for colon cancer prevention","volume":"90","author":"Meyskens","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2022060815280835000_ bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022060815280835000_ bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(98)00274-5","article-title":"Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology","volume":"105","author":"McCarthy","year":"1998","journal-title":"Am J Med"},{"key":"2022060815280835000_ bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(99)00366-6","article-title":"Comparative toxicity of nonsteroidal anti-inflammatory drugs","volume":"107","author":"McCarthy","year":"1999","journal-title":"Am J Med"},{"key":"2022060815280835000_ bib31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N Engl J Med"},{"key":"2022060815280835000_ bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2004","journal-title":"JAMA"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/1\/1\/32\/2241737\/32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/1\/1\/32\/2241737\/32.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:28:57Z","timestamp":1654687737000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/1\/1\/32\/46365\/Difluoromethylornithine-Plus-Sulindac-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,9]]},"published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-08-0042","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22523412.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543747","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543747.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22523412","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}